Floatz logo

Pregabalin

Chronic Pancreatitis

Asian Institute of Gastroenterology, IndiaSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Chronic Pancreatitis cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Johns Hopkins University
Phase 3BB
Pancrelipase
Changhai Hospital
Phase 4BB
Triamcinalone
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 3BB
Namisol
Radboud University Medical Center
Phase 2B
Pioglitazone
University of Michigan
Phase 2B

View all 21 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
Depressive Disorder, MajorDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →